FDA Import Refusal 799-3605349-5/31/1 — Pharmascience Inc.
The FDA refused shipment 799-3605349-5/31/1 from Pharmascience Inc. (Canada) on March 9, 2023. The refused product falls under Drugs and Biologics — METHOTREXATE (ANTI-NEOPLASTIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- March 9, 2023
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 62IDA31 METHOTREXATE (ANTI-NEOPLASTIC)
- Charges
- 118,75